Tumour treatments may need a rethink.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Quintana, E. et al. Nature 456, 593–598 (2008).
Eaves, C. J. Nature 456, 581–582 (2008).
Lapidot, T. et al. Nature 367, 645–648 (1994).
Kelly, P. N., Dakic, A., Adams, J. M., Nutt, S. L. & Strasser, A. Science 317, 337 (2007).
Additional information
See also Authors, page xiii
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Baker, M. Melanoma in mice casts doubt on scarcity of cancer stem cells. Nature 456, 553 (2008). https://doi.org/10.1038/456553a
Published:
Issue Date:
DOI: https://doi.org/10.1038/456553a
This article is cited by
-
The network of epithelial–mesenchymal transition: potential new targets for tumor resistance
Journal of Cancer Research and Clinical Oncology (2015)
-
Notch-1 signaling promotes the cyclinD1-dependent generation of mammary tumor-initiating cells that can revert to bi-potential progenitors from which they arise
Oncogene (2013)
